Acenocoumarol is indicated for:
Population group: both men and women, only adults (18 years old or older)
Treatment and prevention of thromboembolic diseases.
For this indication, competent medicine agencies globally authorize below treatments (click for details):
Acenocoumarol is contraindicated in the following cases: